4.7 Review

Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling

期刊

CARDIOVASCULAR RESEARCH
卷 86, 期 2, 页码 236-242

出版社

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvq045

关键词

Angiogenesis; Cell therapy; Gene therapy; HIF-1; Hypoxia; Vascularization

资金

  1. American Diabetes Association [1-06-RA-121]
  2. NIH [R01-HL55338, P20-GM78494, P01-HL65608, N01-HV28180]
  3. Johns Hopkins Institute for Cell Engineering
  4. Chilean Ministry of Planning (MIDEPLAN)
  5. Department of Nephrology, School of Medicine, Pontificia Universidad Catolica de Chile
  6. DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER
  7. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, R01HL055338] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078494] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The vascular system delivers oxygen and nutrients to every cell in the vertebrate organism. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of hypoxic/ischaemic vascular responses, driving transcriptional activation of hundreds of genes involved in vascular reactivity, angiogenesis, arteriogenesis, and the mobilization and homing of bone marrow-derived angiogenic cells. This review will focus on the pivotal role of HIF-1 in vascular homeostasis, the involvement of HIF-1 in vascular diseases, and recent advances in targeting HIF-1 for therapy in preclinical models.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据